Workflow
融资融券
icon
Search documents
奋达科技1月15日获融资买入4035.44万元,融资余额6.87亿元
Xin Lang Cai Jing· 2026-01-16 01:25
Group 1 - The core viewpoint of the news is that Fenda Technology's stock experienced a decline of 1.55% on January 15, with a trading volume of 508 million yuan, indicating a challenging market environment for the company [1] - As of January 15, Fenda Technology's financing balance reached 6.92 billion yuan, with a net financing outflow of 1926.14 million yuan for the day, suggesting a high level of investor caution [1] - The company's main business revenue composition includes 46.73% from audio products, 31.58% from health appliances, 8.76% from smart locks, and 4.76% from smart wearable products, highlighting its diverse product portfolio [1] Group 2 - As of September 30, Fenda Technology reported a total of 225,000 shareholders, an increase of 9.15% from the previous period, indicating growing interest among investors [2] - For the period from January to September 2025, Fenda Technology achieved a revenue of 1.99 billion yuan, a year-on-year decrease of 15.46%, and a net profit attributable to shareholders of 12.78 million yuan, down 91.65% year-on-year, reflecting significant financial challenges [2] - The company has not distributed any dividends in the past three years, with a total payout of 362 million yuan since its A-share listing, indicating a focus on reinvestment or financial difficulties [3]
中国汽研1月15日获融资买入1485.75万元,融资余额2.40亿元
Xin Lang Cai Jing· 2026-01-16 01:25
分红方面,中国汽研A股上市后累计派现28.48亿元。近三年,累计派现10.74亿元。 机构持仓方面,截止2025年9月30日,中国汽研十大流通股东中,中欧养老混合A(001955)位居第三 大流通股东,持股1283.44万股,相比上期增加382.41万股。中欧睿见混合A(010429)位居第五大流通 股东,持股730.99万股,相比上期增加249.33万股。农银新能源混合A(002190)位居第六大流通股 东,持股681.01万股,持股数量较上期不变。香港中央结算有限公司位居第七大流通股东,持股661.68 万股,相比上期增加226.42万股。南方中证500ETF(510500)位居第八大流通股东,持股586.92万股, 相比上期减少11.16万股。工银文体产业股票A(001714)位居第九大流通股东,持股564.15万股,相比 上期减少156.97万股。华商盛世成长混合(630002)退出十大流通股东之列。 资料显示,中国汽车工程研究院股份有限公司位于重庆市北部新区金渝大道9号,成立日期2001年1月11 日,上市日期2012年6月11日,公司主营业务涉及汽车技术服务和装备制造业务。主营业务收入构成 为:汽 ...
国恩股份1月15日获融资买入1260.59万元,融资余额4.01亿元
Xin Lang Zheng Quan· 2026-01-16 01:25
1月15日,国恩股份涨0.39%,成交额1.24亿元。两融数据显示,当日国恩股份获融资买入额1260.59万 元,融资偿还1025.44万元,融资净买入235.15万元。截至1月15日,国恩股份融资融券余额合计4.01亿 元。 截至9月30日,国恩股份股东户数1.27万,较上期减少20.62%;人均流通股13940股,较上期增加 25.97%。2025年1月-9月,国恩股份实现营业收入154.97亿元,同比增长9.44%;归母净利润6.15亿元, 同比增长34.24%。 分红方面,国恩股份A股上市后累计派现4.77亿元。近三年,累计派现1.90亿元。 机构持仓方面,截止2025年9月30日,国恩股份十大流通股东中,泉果旭源三年持有期混合A (016709)位居第五大流通股东,持股543.41万股,为新进股东。香港中央结算有限公司位居第八大流 通股东,持股315.28万股,相比上期减少230.06万股。万家人工智能混合A(006281)位居第十大流通 股东,持股278.61万股,为新进股东。富国均衡优选混合(010662)、富国成长领航混合(010966)退 出十大流通股东之列。 责任编辑:小浪快报 融资方面, ...
国盛证券1月15日获融资买入7792.52万元,融资余额7.44亿元
Xin Lang Cai Jing· 2026-01-16 01:22
Group 1 - On January 15, Guosheng Securities experienced a decline of 3.21% with a trading volume of 693 million yuan [1] - The financing data for Guosheng Securities on the same day showed a financing purchase amount of 77.93 million yuan and a net financing purchase of 22.13 million yuan, with a total financing and securities balance of 750 million yuan [1] - The current financing balance of Guosheng Securities is 744 million yuan, accounting for 2.76% of the circulating market value, which is above the 50th percentile level over the past year, indicating a relatively high position [1] Group 2 - As of December 31, Guosheng Securities had 104,400 shareholders, a decrease of 9.97% from the previous period, while the average circulating shares per person increased by 11.08% to 15,549 shares [2] - For the period from January to September 2025, Guosheng Securities reported an operating income of 1.23 million yuan, a year-on-year decrease of 25.09%, while the net profit attributable to shareholders increased by 191.21% to 242 million yuan [2] - Since its A-share listing, Guosheng Securities has distributed a total of 264 million yuan in dividends, with no dividends distributed in the last three years [2]
中国稀土1月15日获融资买入1.87亿元,融资余额22.78亿元
Xin Lang Cai Jing· 2026-01-16 01:20
融券方面,中国稀土1月15日融券偿还1.51万股,融券卖出7800.00股,按当日收盘价计算,卖出金额 41.50万元;融券余量26.78万股,融券余额1424.70万元,低于近一年40%分位水平,处于较低位。 资料显示,中国稀土集团资源科技股份有限公司位于江西省赣州市章贡区章江南大道18号豪德银座A栋 14、15层,成立日期1998年6月17日,上市日期1998年9月11日,公司主营业务涉及稀土冶炼分离及稀土 技术研发及服务。主营业务收入构成为:稀土氧化物63.51%,稀土金属及合金35.95%,其他(补 充)0.35%,技术服务收入0.18%。 来源:新浪证券-红岸工作室 1月15日,中国稀土涨1.78%,成交额21.27亿元。两融数据显示,当日中国稀土获融资买入额1.87亿 元,融资偿还1.97亿元,融资净买入-952.31万元。截至1月15日,中国稀土融资融券余额合计22.92亿 元。 融资方面,中国稀土当日融资买入1.87亿元。当前融资余额22.78亿元,占流通市值的4.03%,融资余额 超过近一年80%分位水平,处于高位。 截至12月19日,中国稀土股东户数22.90万,较上期减少3.74%;人均 ...
江顺科技振幅18.27%,机构龙虎榜净买入1835.98万元
融资融券数据显示,该股最新(1月14日)两融余额为1.60亿元,其中,融资余额为1.59亿元,融券余额 为50.60万元。近5日融资余额合计增加2369.30万元,增幅为17.50%,融券余额合计增加13.05万元,增 幅34.77%。(数据宝) 江顺科技今日下跌6.57%,全天换手率39.59%,成交额7.01亿元,振幅18.27%。龙虎榜数据显示,机构 净买入1835.98万元,营业部席位合计净买入1324.66万元。 深交所公开信息显示,当日该股因日振幅值达18.27%上榜,机构专用席位净买入1835.98万元。 证券时报·数据宝统计显示,上榜的前五大买卖营业部合计成交3.24亿元,其中,买入成交额为1.78亿 元,卖出成交额为1.46亿元,合计净买入3160.64万元。 具体来看,今日上榜的营业部中,共有5家机构专用席位现身,即买二、买三、买四、买五、卖一、卖 二,合计买入金额1.12亿元,卖出金额9409.52万元,合计净买入1835.98万元。 近半年该股累计上榜龙虎榜7次,上榜次日股价平均跌2.34%,上榜后5日平均涨0.57%。 资金流向方面,今日该股主力资金净流出9034.49万元,其中,特 ...
美新科技涨5.37%,成交额1.81亿元,近5日主力净流入1051.20万
Xin Lang Cai Jing· 2026-01-15 08:15
Group 1 - The core viewpoint of the article highlights the recent performance of Meixin Technology, which saw a 5.37% increase in stock price, with a trading volume of 181 million yuan and a market capitalization of 2.496 billion yuan [1] - The company is located in Huizhou, Guangdong Province, and is positioned to benefit from the Greater Bay Area and the depreciation of the RMB [2] - According to the 2024 annual report, overseas revenue accounts for 97.08% of the company's total revenue, benefiting from the depreciation of the RMB [3] Group 2 - In terms of capital analysis, the main net inflow today was 5.3148 million yuan, accounting for 0.03%, with the industry ranking at 11 out of 76, indicating a continuous increase in main capital over the past two days [4] - The average trading cost of the stock is 19.65 yuan, with recent rapid accumulation of shares, suggesting short-term trading opportunities within the price range of 21.28 yuan (resistance) and 20.81 yuan (support) [6] - Meixin Technology, established on June 16, 2004, primarily engages in the research, production, and sales of plastic-wood composite materials, with main business revenue composition being 55.37% from wall panels and 44.17% from outdoor flooring [7]
安联锐视跌2.22%,成交额1.79亿元,近5日主力净流入-1339.60万
Xin Lang Cai Jing· 2026-01-15 07:38
Core Viewpoint - The company, Anlian Ruishi, is experiencing a decline in revenue and profit, while also benefiting from the depreciation of the RMB due to its high overseas revenue ratio. Group 1: Company Overview - Anlian Ruishi Technology Co., Ltd. specializes in the research, development, production, and sales of security video surveillance products, with a revenue composition of 99.63% from these products [7] - The company was established on August 6, 2007, and went public on August 5, 2021 [7] - As of January 9, the number of shareholders is 4,974, a decrease of 12.58% from the previous period, while the average circulating shares per person increased by 14.39% [7] Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 334 million yuan, a year-on-year decrease of 39.63%, and a net profit attributable to the parent company of 15.17 million yuan, down 79.85% year-on-year [7] - The company has distributed a total of 377 million yuan in dividends since its A-share listing, with 253 million yuan distributed over the past three years [8] Group 3: Market Position and Trends - The company has a strong focus on the development of artificial intelligence applications in the surveillance industry, including facial recognition, human detection, and vehicle detection technologies [2] - The company has a high overseas revenue ratio of 92.33%, benefiting from the depreciation of the RMB [3] - Anlian Ruishi is actively expanding into the smart city sector, developing multiple product lines tailored for this market [2]
三七互娱跌2.06%,成交额21.13亿元,主力资金净流出1.19亿元
Xin Lang Cai Jing· 2026-01-15 06:37
Core Viewpoint - The stock of Sanqi Interactive Entertainment has experienced fluctuations, with a recent decline of 2.06%, while showing significant growth in the past months, indicating a volatile yet potentially rewarding investment opportunity in the gaming sector [1]. Group 1: Stock Performance - As of January 15, Sanqi Interactive's stock price is 28.96 CNY per share, with a market capitalization of 640.66 billion CNY [1]. - The stock has increased by 22.71% year-to-date, with a 39.90% rise over the past 20 days and a 46.63% increase over the past 60 days [1]. - The trading volume on January 15 reached 21.13 billion CNY, with a turnover rate of 4.50% [1]. Group 2: Financial Performance - For the period from January to September 2025, Sanqi Interactive reported a revenue of 124.61 billion CNY, a year-on-year decrease of 6.59%, while the net profit attributable to shareholders increased by 23.57% to 23.45 billion CNY [2]. - The company has distributed a total of 115.00 billion CNY in dividends since its A-share listing, with 63.88 billion CNY distributed in the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders has increased to 159,300, with an average of 10,034 circulating shares per person, a decrease of 5.54% [2]. - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 128 million shares, a decrease of 4.39 million shares from the previous period [3]. - New entrants among the top shareholders include the E Fund CSI Artificial Intelligence Theme ETF and the Guotai CSI Animation Game ETF [3].
艾力斯跌2.01%,成交额3.57亿元,主力资金净流出1483.23万元
Xin Lang Cai Jing· 2026-01-15 06:22
截至9月30日,艾力斯股东户数1.91万,较上期增加46.82%;人均流通股23551股,较上期减少31.89%。 2025年1月-9月,艾力斯实现营业收入37.33亿元,同比增长47.35%;归母净利润16.16亿元,同比增长 52.01%。 分红方面,艾力斯A股上市后累计派现6.53亿元。 1月15日,艾力斯盘中下跌2.01%,截至13:55,报100.15元/股,成交3.57亿元,换手率0.78%,总市值 450.68亿元。 资金流向方面,主力资金净流出1483.23万元,特大单买入1006.09万元,占比2.82%,卖出1029.79万 元,占比2.89%;大单买入5937.22万元,占比16.65%,卖出7396.75万元,占比20.75%。 艾力斯今年以来股价跌3.84%,近5个交易日跌3.89%,近20日跌0.44%,近60日跌3.63%。 资料显示,上海艾力斯医药科技股份有限公司位于上海市浦东新区周浦镇凌霄花路268号,成立日期 2004年3月22日,上市日期2020年12月2日,公司主营业务涉及创新药物的研发、生产和销售。主营业务 收入构成为:药品销售收入99.93%,推广服务收入0.06% ...